USPTO Issues 14-3-3η Patent: Good News for RA Patients

NEWS RELEASE | OCTOBER 17, 2017 Vancouver, BC —  Augurex Life Sciences Corp is proud to announce that 14-3-3η, a novel rheumatoid arthritis (RA) biomarker, is paving a future for better patient… read more →